Language: HOME CHEMICAL COMPOUNDS CENTRE FOR RARE DISEASES BIOECONOMY MEDIA POLICIES AND CERTIFICATIONS CONTACT US (ITALIANO) “THE VACCINE ACTIVATES MANY ANTIBODIES”. STEPS FORWARD THANKS TO THE TESTS ON ELDERLY PEOPLE 27 OCTOBER 2020 COMMENTS (0) LIKE Sorry, this entry is only available in Italian. LIKE (ITALIANO) “THE VACCINE ACTIVATES MANY ANTIBODIES”. STEPS FORWARD THANKS TO THE TESTS ON ELDERLY PEOPLE ABOUT THE AUTHOR: INFO@IWEBYOU.IT RECENT POSTS (Italiano) Oxford vaccine up to 90% effective – trials (Italiano) Interview with Piero Di Lorenzo «The Oxford vaccine has an efficacy of 90%» (Italiano) Interview with Matteo Liguori. Research needs time (Italiano) “The vaccine activates many antibodies”. Steps forward thanks to the tests on elderly people (Italiano) Covid vaccine, IRBM (Pomezia, Rome): «First doses of AstraZeneca vaccine within December, the clinical trials are about to be completed» Contact Us Ph: +39.06.91093692 Fax: +39.06.91093654 Mail: info@cnccs CNCCS Scarl Collection of National Chemical Compounds and Screening Center Via Pontina km 30,600 – 00071 Pomezia (RM) News (Italiano) Oxford vaccine up to 90% effective – trials (Italiano) Interview with Piero Di Lorenzo «The Oxford vaccine has an efficacy of 90%» (Italiano) Interview with Matteo Liguori. Research needs time (Italiano) “The vaccine activates many antibodies”. Steps forward thanks to the tests on elderly people (Italiano) Compliance Privacy Cookies policy Code of Ethics Codice Etico Modello Organizzativo di Gestione e Controllo ex D.Lgs. 231/2001 – Parte generale_allegato Partners

Language: HOME CHEMICAL COMPOUNDS CENTRE FOR RARE DISEASES BIOECONOMY MEDIA POLICIES AND CERTIFICATIONS CONTACT US Video Gallery CNCCS’s Video 00:00 23/11/2012: Bioeconomy Rome 2012 - TG3 23/11/2012: Bioeconomy Rome 2012 - TG3 Contact Us Ph: +39.06.91093692 Fax: +39.06.91093654 Mail: info@cnccs CNCCS Scarl Collection of National Chemical Compounds and Screening Center Via Pontina km 30,600 – 00071 Pomezia (RM) News (Italiano) Oxford vaccine up to 90% effective – trials (Italiano) Interview with Piero Di Lorenzo «The Oxford vaccine has an efficacy of 90%» (Italiano) Interview with Matteo Liguori. Research needs time (Italiano) “The vaccine activates many antibodies”. Steps forward thanks to the tests on elderly people (Italiano) Compliance Privacy Cookies policy Code of Ethics Codice Etico Modello Organizzativo di Gestione e Controllo ex D.Lgs. 231/2001 – Parte generale_allegato Partners